|
FY2025
12 months to Jan 2, 2026
|
FY2024
12 months to Dec 27, 2024
|
FY2023
12 months to Dec 29, 2023
|
FY2022
12 months to Dec 30, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses: | |||||
| General and administrative | |||||
| Selling and marketing | |||||
| Research and development | |||||
| Merger transaction and related costs | |||||
| Restructuring, impairment and related charges | |||||
| Total selling, general and administrative expenses | |||||
| Operating income (loss) | |||||
| Other income, net: | |||||
| Interest income, net | |||||
| Gain (loss) on foreign currency transactions | |||||
| Royalty income | |||||
| Other income, net | |||||
| Total other income, net | |||||
| Income (loss) before income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net income (loss) | |||||
| Net income (loss) per share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average shares outstanding: | |||||
| Basic | |||||
| Diluted |
Loading...
